In Poland, surgeons and internists often have different approaches to perioperative anticoagulation. What would be your advice for a physician who struggles to find a middle ground between the expectations of a surgeon and an internist?
Should a patient with a history of cerebral vein thrombosis travel by plane? What if the patient is currently not on anticoagulants?
Is it advisable to screen patients for the most common genetic thrombophilias before starting hormonal contraception?
Which hormonal contraceptives, routes of administration, and regimens are associated with the lowest risk of thrombosis?
Should female patients with a history of proximal thrombosis (affecting iliac vein or inferior vena cava) plan to become pregnant? What should be our recommendation for such patients? Does lack of recanalization of the affected vein pose additional problems?
What is new in the updated American College of Chest Physicians antithrombotic guidelines? What are the most important changes?
When to use bridging therapy? Do we need it for novel oral anticoagulants?
Is hormonal contraception and hormone replacement therapy feasible following an episode of pulmonary thromboembolism or deep vein thrombosis?
In the setting of general medical practice, what is the necessary extent of knowledge on antithrombotic treatment in patients undergoing invasive procedures?
How should we manage a patient who has had a second episode of thrombosis while receiving adequate antithrombotic treatment?
English
Polski
Español
українська